Haemolytic uraemic syndrome in a renal transplant recipient during OKT3 therapy

Nephrol Dial Transplant. 1994;9(8):1191-3. doi: 10.1093/ndt/9.8.1191.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Graft Survival
  • Hemolytic-Uremic Syndrome / etiology*
  • Hemolytic-Uremic Syndrome / pathology
  • Humans
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / physiology
  • Male
  • Muromonab-CD3 / adverse effects*

Substances

  • Muromonab-CD3